Masimo Announces Recent Study Monitoring Methemoglobin Levels During Administration of Inhaled Nitric Oxide (Masimo Corporation)
(WorldNews Health)

(Source: Masimo Corporation) IRVINE, Calif.--(BUSINESS WIRE)--Feb. 21, 2017-- Masimo (NASDAQ: MASI) announced today the findings of a recent study conducted on children admitted to a Ugandan hospital with fever and malaria, in which Masimo`s noninvasive measurement SpMet was used to monitor methemoglobin (MetHb) levels. One group of children with severe malaria was selected to receive inhaled nitric oxide (iNO) treatment as an adjunct to intravenous therapy while a placebo group received room air. Both of these groups were monitored with SpMet. Red blood cells containing hemoglobin can become oxidized in the presence of certain drugs and compounds, including nitric oxide, changing it to...